December 30, 2008 – Merit Medical Systems said it has received FDA 510(k) clearance for its Miser contrast management system.
The product has patents pending and will be released during the first quarter of 2009.
"With the rising cost of health care, this product allows clinicians to more efficiently manage contrast media, which is a costly part of a diagnostic or interventional procedure,” said Fred P. Lampropoulos, Merit's chairman and CEO. "We believe that this product will enhance both the stand-alone and kit segments of our business."
For more information: www.merit.com
July 26, 2024 
